September 25, 2008 5:30 PM
- Text
New Media Opportunity for Drug Firms: Video Games
Perhaps you're tired of seeing the same healthy-looking people in drug ads hiking across craggy rocks or picking up their grandkids or wafting gently off to sleep while a slew of side effects (in fine print, natch) scrolls quickly by. If so, the pharmaceutical industry has another offer for you: How about a quick game of "Viva Cruiser"? Or "Captain Novolin?"
Just kidding -- neither of those drug-promotion videogames (for Viagra and a branded insulin, respectively) are actually available anymore. But as BNET Pharma blogger Jim Edwards notes today, Sanofi-Aventis has just become the latest drug company to plunge into the online videogame business with "Silence Your Rooster," a game that pits a pillow-armed insomniac against pop-up roosters that threaten his or her night's sleep. Of course, it's intended to raise "brand awareness" of the sleepy drug Ambien.
The games may not be gripping, and of course it's far from clear whether they actually help sell drugs. But they're clear evidence that drugmakers are beginning to stake out some interesting territory in Internet media.
© 2008 CBS Interactive Inc.. All Rights Reserved.
Just kidding -- neither of those drug-promotion videogames (for Viagra and a branded insulin, respectively) are actually available anymore. But as BNET Pharma blogger Jim Edwards notes today, Sanofi-Aventis has just become the latest drug company to plunge into the online videogame business with "Silence Your Rooster," a game that pits a pillow-armed insomniac against pop-up roosters that threaten his or her night's sleep. Of course, it's intended to raise "brand awareness" of the sleepy drug Ambien.
The games may not be gripping, and of course it's far from clear whether they actually help sell drugs. But they're clear evidence that drugmakers are beginning to stake out some interesting territory in Internet media.
-
David Hamilton is the assistant managing editor of CNET News. He has been writing and editing business and tech coverage for about two decades -- the majority of that at the Wall Street Journal in both Tokyo and San Francisco.
Follow on Twitter »
Add A Comment +
Popular Now in MoneyWatch
- Report: Zuckerberg drops off 40 richest list
- What are the most dangerous websites?
- Facebook shares close at new low
- 10 Best Countries To Live and Work Abroad
- 5 reasons to invest in a 529 plan
- Average home prices hit mid-2002 levels
- 4 Things Not to Buy at Costco
- Top 10 Cities for Single Men
- How to craft an email that gets a reply
- Used Cars: 5 to Avoid (and 5 Better Alternatives)
- The 7 Interview Questions You Must Ask
- Why leaders should scowl
- Reverse Cell Phone Lookup Service is Free and Simple
- Radioactive bluefin tuna crossed the Pacific to US
- Law firm Dewey & LeBoeuf files for bankruptcy
- Why renters should consider buying a home






